Laboratory Testing Division (LTD) is a comprehensive integrated testing platform supporting customers across the full spectrum of their development efforts to deliver innovative medicines to patients. We integrate CMC, Pharmacology, DMPK, Toxicology and Bioanalysis services into a complete “package”, bringing research from Discovery to successful IND and Beyond.

WuXi Clinical, is a global Contract Research Organization (CRO) providing a comprehensive range of services in clinical development. We provide Phase I to Phase IV clinical development services & BE (Bioequivalence), for products including pharmaceuticals, biologics, and medical devices.

WuXi MedKey focuses on the SMO on-site execution of clinical studies. We have more than 4,000 CRCs in over 160 cities across China. In good cooperation with more than 1,000 hospitals in China, we provide clinical trial services for more than 600 pharmas, CROs and biotech companies all over the world. We have clinical operation experience of more than 1600 projects, including endocrinology, cardiology, dermatology, respiration, neurology, rheumatology, ophthalmology, nephrology, Assisted Reproductive Technology (ART), oncology, and medical devices.